These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25782174)

  • 41. Endocrine-paracrine (APUD, neuroendocrine) cells in the normal and pathologic prostate.
    Di Sant'agnese PA
    Bull Assoc Anat (Nancy); 1991 Jun; 75(229):63-7. PubMed ID: 1685682
    [No Abstract]   [Full Text] [Related]  

  • 42. A novel neoplastic primary tumor-derived human prostate epithelial cell line.
    Ko D; Gu Y; Yasunaga Y; Nakamura K; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Arnstein P; Taylor DO; Hukku B; Rhim JS
    Int J Oncol; 2003 Jun; 22(6):1311-7. PubMed ID: 12738999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate.
    Fang X; Gyabaah K; Nickkholgh B; Cline JM; Balaji KC
    Prostate; 2015 Jun; 75(9):988-1000. PubMed ID: 25753731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer.
    Yu JJ; Yan T
    Aging Male; 2010 Sep; 13(3):159-65. PubMed ID: 20136572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis?
    Roy-Burman P; Zheng J; Miller GJ
    Mol Med Today; 1997 Nov; 3(11):476-82. PubMed ID: 9430782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate stem cells: from development to cancer.
    Signoretti S; Loda M
    Semin Cancer Biol; 2007 Jun; 17(3):219-24. PubMed ID: 16781871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Harvesting Human Prostate Tissue Material and Culturing Primary Prostate Epithelial Cells.
    Frame FM; Pellacani D; Collins AT; Maitland NJ
    Methods Mol Biol; 2016; 1443():181-201. PubMed ID: 27246341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Material characterization of ex vivo prostate tissue via spherical indentation in the clinic.
    Carson WC; Gerling GJ; Krupski TL; Kowalik CG; Harper JC; Moskaluk CA
    Med Eng Phys; 2011 Apr; 33(3):302-9. PubMed ID: 21093348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Differential-diagnostic value of changes in nuclear ploidy of prostate epithelial cells during the carcinogenesis process].
    Avtandilov GG; Gundorova LV; Saniev KB
    Urologiia; 2002; (3):8-11. PubMed ID: 12180069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
    Bonkhoff H; Remberger K
    Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
    Lee MC; Moussa AS; Yu C; Kattan MW; Magi-Galluzzi C; Jones JS
    J Urol; 2010 Nov; 184(5):1958-62. PubMed ID: 20846692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
    Jiang W; Ding Y; Shen Y; Fan L; Zhou L; Li Z; Zheng Y; Zhao P; Liu L; Tong Z; Fang W; Wang W
    Oncotarget; 2017 Jan; 8(3):5016-5025. PubMed ID: 28008139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Osteosarcoma of the urinary bladder with a prostatic cancer as a 2d primary tumor].
    Schütze U
    Zentralbl Allg Pathol; 1986; 131(5):423-7. PubMed ID: 3461627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostate cancer: A step to identifying men at high risk of metastatic disease.
    Thoma C
    Nat Rev Urol; 2016 Sep; 13(9):493. PubMed ID: 27455893
    [No Abstract]   [Full Text] [Related]  

  • 58. Cell biology: Prostate cancer in 3D.
    Jarchum I
    Nat Methods; 2014 Nov; 11(11):1096. PubMed ID: 25551127
    [No Abstract]   [Full Text] [Related]  

  • 59. The concept of evolution in the pathogenesis and treatment of prostate cancer.
    Garcia-Schurmann M; Coffey DS
    Br J Urol; 1997 Apr; 79 Suppl 2():9-17. PubMed ID: 9126065
    [No Abstract]   [Full Text] [Related]  

  • 60. Innovation: organoids-a better model for prostate cancer.
    Phillips R
    Nat Rev Urol; 2014 Nov; 11(11):604. PubMed ID: 25245237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.